Could your Brain's decline predict a fall? new study investigates
NCT ID NCT04754906
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at how age-related changes in thinking skills, like memory and planning, affect movement and increase fall risk. Researchers will test arm and balance tasks in 684 adults aged 55 and older, including those with mild cognitive issues. The goal is to better understand falls and improve prevention and rehabilitation in the long run.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could improve fall prevention and rehabilitation strategies for older adults with mild cognitive decline.
- What could go wrong
- This is an observational study, not a treatment trial. It is early-stage research and may not directly lead to practical interventions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 684 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2021
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
young subjects, elderly neurotypical subjects and elderly subjects with mild cognitive disorder
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Neurotypical subjects group: * Person aged 18 to 40 years * Person who has given oral consent * Affiliated to national health insurance * Right-handed person 2. Group of elderly neurotypical subjects: * Person over 55 years of age * Person who has given oral consent * Affiliated to national health insurance * No cognitive problems (MMSE score \>26) * Right-handed person 3. Elderly mild cognitive disorder subject group: * Person over 55 years of age * Person who has given oral consent * Diagnosis of Mild Cognitive Disorder made by a neurologist at the Centre Mémoire Ressources et Recherche (CMRR) of the University Hospital of Dijon, following the recommendations of the National Institute for Aging and Alzheimer's Association (Albert et al., 2011) This diagnosis is based on psychometric tests, brain imaging and the evolution of cognitive disorders, including an MMSE test. * Right-handed person Exclusion Criteria: * Neurological or psychiatric history with the exception of the TCL group. * Follow-up of drug treatment in the last three months that may affect cognitive and/or motor skills. * Received a shoulder prosthesis on the dominant side. * Received a hip and/or knee replacement less than a year ago. * Disabling joint disease of the hip or knee shoulder * Protected adults (curatorship, guardianship) * Person deprived of their liberty b judicial or administrative decision * Pregnant, parturient or breastfeeding woman * Major unable to consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mild cognitive disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Chu Dijon Bourgogne
RECRUITINGDijon, 21000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.